139 related articles for article (PubMed ID: 3160311)
1. Isolation of an acidic polysaccharide antigen from Propionibacterium acnes.
Iversen OJ; Dalen AB; Svindland HB
Arch Dermatol Res; 1985; 277(3):225-9. PubMed ID: 3160311
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris.
Dalen A; Hellgren L; Iversen OJ; Vincent J
Arch Dermatol Res; 1980; 269(3):253-9. PubMed ID: 6453560
[TBL] [Abstract][Full Text] [Related]
3. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients.
Webster GF; Indrisano JP; Leyden JJ
J Invest Dermatol; 1985 Jun; 84(6):496-500. PubMed ID: 3158714
[TBL] [Abstract][Full Text] [Related]
4. Detection of Propionibacterium acnes polypeptides which have stimulated an immune response in acne patients but not in normal individuals.
Holland KT; Holland DB; Cunliffe WJ; Cutcliffe AG
Exp Dermatol; 1993 Feb; 2(1):12-6. PubMed ID: 8156165
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a polysaccharide antigen from Propionibacterium acnes released by a glycine-specific chemical protein degradation procedure.
Verostek MF; Bartholomew LE; Weber P
Z Naturforsch C J Biosci; 1990; 45(7-8):797-804. PubMed ID: 2282114
[TBL] [Abstract][Full Text] [Related]
7. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
8. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
[TBL] [Abstract][Full Text] [Related]
9. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
[TBL] [Abstract][Full Text] [Related]
10. Partial purification and some properties of a lipase from Corynebacterium acnes.
Hassing GS
Biochim Biophys Acta; 1971 Aug; 242(2):381-94. PubMed ID: 4258517
[No Abstract] [Full Text] [Related]
11. Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.
Jappe U; Ingham E; Henwood J; Holland KT
Br J Dermatol; 2002 Feb; 146(2):202-9. PubMed ID: 11903228
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effect of killed Propionibacterium acnes and its purified soluble polysaccharide on mouse bone marrow stem cells and dendritic cell differentiation.
Squaiella CC; Ananias RZ; Mussalem JS; Braga EG; Rodrigues EG; Travassos LR; Lopes JD; Longo-Maugéri IM
Immunobiology; 2006; 211(1-2):105-16. PubMed ID: 16446175
[TBL] [Abstract][Full Text] [Related]
13. Levels of antibody to Staphylococcus epidermidis in patients with acne vulgaris.
Puhvel SM; Warnick MA; Sternberg TH
Arch Dermatol; 1965 Jul; 92(1):88-90. PubMed ID: 11850964
[TBL] [Abstract][Full Text] [Related]
14. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.
Karvonen SL; Räsänen L; Cunliffe WJ; Holland KT; Karvonen J; Reunala T
Dermatology; 1994; 189(4):344-9. PubMed ID: 7873817
[TBL] [Abstract][Full Text] [Related]
15. STUDY OF ANTIBODY LEVELS TO CORYNEBACTERIUM ACNES. IN THE SERUM OF PATIENTS WITH ACNE VULGARIS, USING BACTERIAL AGGLUTINATION, AGAR GEL IMMUNODIFFUSION, AND IMMUNOFLUORESCENCE TECHNIQUES.
PUHVEL SM; BARFATANI M; WARNICK M; STERNBERG TH
Arch Dermatol; 1964 Oct; 90():421-7. PubMed ID: 14184490
[No Abstract] [Full Text] [Related]
16. [Occurrence and levels of serum antibodies against Propionibacterium antigens in persons of various ages].
Kałuzewski S; Kasprowicz A
Med Dosw Mikrobiol; 1987; 39(3):137-42. PubMed ID: 2959828
[No Abstract] [Full Text] [Related]
17. Anti-P. acnes antibody in comedonal extracts.
Knop J; Ollefs K; Frosch PJ
J Invest Dermatol; 1983 Jan; 80(1):9-12. PubMed ID: 6217259
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory acne represents hypersensitivity to Propionibacterium acnes.
Webster GF
Dermatology; 1998; 196(1):80-1. PubMed ID: 9557234
[TBL] [Abstract][Full Text] [Related]
19. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
20. Variable expression of immunoreactive surface proteins of Propionibacterium acnes.
Lodes MJ; Secrist H; Benson DR; Jen S; Shanebeck KD; Guderian J; Maisonneuve JF; Bhatia A; Persing D; Patrick S; Skeiky YAW
Microbiology (Reading); 2006 Dec; 152(Pt 12):3667-3681. PubMed ID: 17159220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
